CORE1: Phase 2, single-arm study of CG0070 combined with pembrolizumab in patients with nonmuscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).

被引：0
|
作者：
Li, Roger
Steinberg, Gary D.
Uchio, Edward M.
Lamm, Donald L.
Shah, Paras
Kamat, Ashish M.
Bivalacqua, Trinity
Packiam, Vignesh T.
Chisamore, Michael Jon
McAdory, John
Grandi, Paola
Hnat, Nataliya
Burke, James
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[2] Univ Chicago Med, Dept Surg, Chicago, IL USA
[3] Univ Calif Orange, Irvine Med Ctr, Orange, CA USA
[4] BCG Onc, Phoenix, AZ USA
[5] Mayo Clin, Rochester, MN USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[7] Johns Hopkins Univ Hosp, Baltimore, MD USA
[8] Univ Iowa, Dept Urol, Iowa City, IA USA
[9] Merck Co & Inc, Kenilworth, NJ USA
[10] CG Oncol, Irvine, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4597
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I trial of intravesical Bacillus Calmette-Guerin combined with intravenous Pembrolizumab in high grade nonmuscle invasive bladder cancer
    Alanee, Shaheen
    El Zawahry, Ahmed
    Sana, Sherjeel
    McVary, Kevin
    Robinson, Kathy
    Rao, Krishna A.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [22] PHASE I TRIAL OF INTRAVESICAL BACILLUS CALMETTE-GUERIN COMBINED WITH INTRAVENOUS PEMBROLIZUMAB IN HIGH GRADE NONMUSCLE INVASIVE BLADDER CANCER
    Alanee, Shaheen
    El-Zawahry, Ahmed
    McVary, Kevin
    Deebajah, Mustafa
    Sana, Sherjeel
    Robinson, Kathy
    Rao, Krishna
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E620 - E621
  • [23] Pembrolizumab in patients with Bacillus Calmette Guerin (BCG)-unresponsive, high-risk non-muscle-invasive bladder cancer (NMIBC): Phase 2 KEYNOTE-057 study
    de Wit, R.
    Kamat, A. M.
    Bellmunt, J.
    Choueiri, T. K.
    Nam, K.
    De Santis, M.
    Dreicer, R.
    Hahn, N. M.
    Perini, R.
    Siefker-Radtke, A. O.
    Sonpavde, G.
    Witjes, J. A.
    Keefe, S.
    Bajorin, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [24] A phase 1 dose-escalation trial of intravesical CG0070 for superficial transitional cell carcinoma (TCC) of the bladder after bacillus Calmette-Guerin (BCG) failure
    Lamm, D
    Stephenson, J
    Tsai, H
    Nemunaitis, J
    Goldstein, M
    Arseneau, J
    Neal, K
    Aimi, J
    Yu, D
    Corman, JM
    McKiernan, JM
    Senzer, N
    Burke, JP
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 272 - 272
  • [25] A Phase 1 Dose-Escalation Trial of Intravesical CG0070 for Superficial Transitional Cell Carcinoma (TCC) of the Bladder after Bacillus Calmette-Guerin (BCG) Failure
    Senzer, Neil
    Nemunaitis, John
    Goldstein, Michael
    Arseneau, James
    Lamm, Don
    Stephenson, Joe
    Tsai, Harry
    Neal, Kristina
    Aimi, Junko
    Yu, D. C.
    Maslyar, Daniel
    Corman, John
    Mckiernan, James
    Burke, James
    [J]. MOLECULAR THERAPY, 2006, 13 : S22 - S22
  • [26] KEYNOTE-057: Phase 2 study of pembrolizumab for patients (pts) with Bacillus Calmette Guerin (BCG)unresponsive, high-risk non-muscle-invasive bladder cancer (NMIBC)
    Kamat, Ashish M.
    Bellmunt, Joaquim
    Choueiri, Toni K.
    Nam, Kijoeng
    De Santis, Maria
    Dreicer, Robert
    Hahn, Noah M.
    Perini, Rodolfo F.
    Siefker-Radtke, Arlene O.
    Sonpavde, Guru
    De Wit, Ronald
    Witjes, Alfred
    Keefe, Stephen Michael
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with nonmuscle-invasive bladder cancer: A meta-analysis
    Kazem Aghamir, Seyed Mohammad
    Khatami, Fatemeh
    Farrokhpour, Hossein
    Reis, Leonardo Oliveira
    Pishkuhi, Mahin Ahmadi
    Mohammad, Abdolreza
    [J]. PLOS ONE, 2022, 17 (05):
  • [28] Pembrolizumab for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG): Phase II KEYNOTE-057 trial
    de Wit, R.
    Kulkarni, G. S.
    Uchio, E.
    Singer, E. A.
    Krieger, L.
    Grivas, P.
    Bajorin, D.
    Seo, H. K.
    Mourey, L.
    Kamat, A.
    Nishiyama, H.
    Kapadia, E.
    Nam, K.
    Frenkl, T.
    Balar, A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 304 - 304
  • [29] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design
    Woldu, Solomon L.
    [J]. JOURNAL OF UROLOGY, 2021, 205 (06): : 1620 - 1620
  • [30] Atezolizumab (atezo) with or without Bacille Calmette-Guerin (BCG) in patients (pts) with high-risk nonmuscle-invasive bladder cancer (NMIBC): Results from a phase Ib/II study.
    Hahn, Noah M.
    Steinberg, Gary D.
    Stratton, Kelly Lynn
    Kopp, Ryan P.
    Sankin, Alexander
    Skinner, Eila C.
    Pohar, Kamal S.
    Gartrell, Benjamin Adam
    Pham, Song
    Rishipathak, Deepali
    Mariathasan, Sanjeev
    Davarpanah, Nicole N.
    Carter, Corey
    Inman, Brant Allen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345